Transient akathisia after the SARS-Cov-2 vaccine

Meagen R. Salinas; Marisara Dieppa

doi:10.1016/j.prdoa.2021.100098

Transient akathisia after the SARS-Cov-2 vaccine

Meagen R. Salinas, Marisara Dieppa

Research output: Contribution to journal › Letter › peer-review

10 Scopus citations

Abstract

We describe a case of transient akathisia after the second dose of the Pfizer COVID-19 vaccine. Movement disorder symptoms such as parkinsonism have been described after other vaccinations and acute COVID-19 infection. This suggests a potential vulnerability of the extrapyramidal system to the immune response against even a component of the virus.

Original language	English (US)
Article number	100098
Journal	Clinical Parkinsonism and Related Disorders
Volume	4
DOIs	https://doi.org/10.1016/j.prdoa.2021.100098
State	Published - Jan 2021

Keywords

Akathisia
Covid-19 Vaccine
SARS-Cov-2 Vaccine

ASJC Scopus subject areas

Clinical Neurology
Cellular and Molecular Neuroscience

Access to Document

10.1016/j.prdoa.2021.100098

Cite this

@article{e5bda08a684448789f24f260a6e0e483,

title = "Transient akathisia after the SARS-Cov-2 vaccine",

abstract = "We describe a case of transient akathisia after the second dose of the Pfizer COVID-19 vaccine. Movement disorder symptoms such as parkinsonism have been described after other vaccinations and acute COVID-19 infection. This suggests a potential vulnerability of the extrapyramidal system to the immune response against even a component of the virus.",

keywords = "Akathisia, Covid-19 Vaccine, SARS-Cov-2 Vaccine",

author = "Salinas, {Meagen R.} and Marisara Dieppa",

note = "Publisher Copyright: {\textcopyright} 2021",

year = "2021",

month = jan,

doi = "10.1016/j.prdoa.2021.100098",

language = "English (US)",

volume = "4",

journal = "Clinical Parkinsonism and Related Disorders",

issn = "2590-1125",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Transient akathisia after the SARS-Cov-2 vaccine

AU - Salinas, Meagen R.

AU - Dieppa, Marisara

PY - 2021/1

Y1 - 2021/1

N2 - We describe a case of transient akathisia after the second dose of the Pfizer COVID-19 vaccine. Movement disorder symptoms such as parkinsonism have been described after other vaccinations and acute COVID-19 infection. This suggests a potential vulnerability of the extrapyramidal system to the immune response against even a component of the virus.

AB - We describe a case of transient akathisia after the second dose of the Pfizer COVID-19 vaccine. Movement disorder symptoms such as parkinsonism have been described after other vaccinations and acute COVID-19 infection. This suggests a potential vulnerability of the extrapyramidal system to the immune response against even a component of the virus.

KW - Akathisia

KW - Covid-19 Vaccine

KW - SARS-Cov-2 Vaccine

UR - http://www.scopus.com/inward/record.url?scp=85116782008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85116782008&partnerID=8YFLogxK

U2 - 10.1016/j.prdoa.2021.100098

DO - 10.1016/j.prdoa.2021.100098

M3 - Letter

C2 - 34113842

AN - SCOPUS:85116782008

SN - 2590-1125

VL - 4

JO - Clinical Parkinsonism and Related Disorders

JF - Clinical Parkinsonism and Related Disorders

M1 - 100098

ER -

Transient akathisia after the SARS-Cov-2 vaccine

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this